Takuma Kato

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Sentinel Lymph Node

Prostate Cancer

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Prostate cancer and prostatic diseases

BJU international

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, Yoichiro Tohi, Hiroshi Fukuhara, Yoichi Fujii, Keiichiro Mori, Takuma Sato, Junichi Inokuchi, Katsuyoshi Hashine, Shinichi Sakamoto, Hidefumi Kinoshita, Koji Inoue, Toshiki Tanikawa, Takanobu Utsumi, Takayuki Goto, Isao Hara, Hiroshi Okuno, Yoshiyuki Kakehi, Mikio Sugimoto
Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN). BJU international (2024)
Takuma Kato, Hiromi Hirama, Toshiyuki Kamoto, Takayuki Goto, Hiroyuki Fujimoto, Shinichi Sakamoto, Nobuo Shinohara, Shin Egawa, Dai Kouguchi, Masashi Nakayama, Katsuyoshi Hashine, Nobuaki Shimizu, Koji Inoue, Tomonori Habuchi, Takaya Hioka, Taizou Shiraishi, Mikio Sugimoto, Yoshiyuki Kakehi
Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan. International journal of clinical oncology (2024)
Takuma Kato, Yoichiro Tohi, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
How widespread is active surveillance of early-stage prostate cancer in Japan? Multicenter questionnaire survey on the status of active surveillance of early-stage prostate cancer in Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Takuma Kato, Yoichiro Tohi, Tomoko Honda, Iori Matsuda, Yu Osaki, Hirohito Naito, Yuki Matsuoka, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto
A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients. International journal of urology : official journal of the Japanese Urological Association (2023)
Shusuke Akamatsu, Naoki Terada, Ryo Takata, Hidefumi Kinoshita, Kimihiro Shimatani, Yukihide Momozawa, Michio Yamamoto, Harue Tada, Naoki Kawamorita, Shintaro Narita, Takuma Kato, Masahiro Nitta, Syuya Kandori, Yusuke Koike, Johji Inazawa, Takahiro Kimura, Hiroko Kimura, Takahiro Kojima, Toshiro Terachi, Mikio Sugimoto, Tomonori Habuchi, Yoichi Arai, Shingo Yamamoto, Tadashi Matsuda, Wataru Obara, Toshiyuki Kamoto, Takahiro Inoue, Hidewaki Nakagawa, Osamu Ogawa
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy. JNCI cancer spectrum 6 (1) (2022)
Takuma Kato, Akira Yokomizo, Ryuji Matsumoto, Yoichiro Tohi, Jimpei Miyakawa, Koji Mitsuzuka, Hiroshi Sasaki, Junichi Inokuchi, Masafumi Matsumura, Shinichi Sakamoto, Hidefumi Kinoshita, Hiroshi Fukuhara, Naoto Kamiya, Ryu Kimura, Masahiro Nitta, Hiroshi Okuno, Koichiro Akakura, Yoshiyuki Kakehi, Mikio Sugimoto
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study. International journal of urology : official journal of the Japanese Urological Association 29 (11) (2022)
Takuma Kato, Yoichiro Tohi, Tomoko Honda, Iori Matsuda, Yu Osaki, Hirohito Naito, Yuki Matsuoka, Homare Okazoe, Rikiya Taoka, Hiroyuki Tsunemori, Nobufumi Ueda, Mikio Sugimoto
A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer. International journal of urology : official journal of the Japanese Urological Association (2022)
Takuma Kato, Hiromi Hirama, Koji Mitsuzuka, Satoru Maruyama, Hiroshi Sasaki, Toshihiro Saito, Ryuji Matsumoto, Shinichi Sakamoto, Yasuyuki Sakai, Hiroshi Fukuhara, Yukio Naya, Hiromasa Tsukino, Isao Hara, Osamu Ogawa, Katsuyoshi Hashine, Fukuta Fumimasa, Akira Yokomizo, Yoichiro Tohi, Yoshiyuki Kakehi, Mikio Sugimoto
Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN. Prostate cancer and prostatic diseases (2021)